Diethyl Ether → Erlotinib Hydrochloride
Reaction equation
[CH3:1][O:2][CH2:3][CH2:4][O:5][C:6]1[CH:7]=[C:8]2[C:20]([NH:21][C:22]3[CH:23]=[CH:24][CH:25]=[C:26]([C:28]#[CH:29])[CH:27]=3)=[N:19][CH:18]=[N:17][C:9]2=[CH:10][C:11]=1[O:12][CH2:13][CH2:14][O:15][CH3:16].C(OCC)C.[ClH:35].C(OCC)C>C(Cl)(Cl)Cl>[CH3:1][O:2][CH2:3][CH2:4][O:5][C:6]1[CH:7]=[C:8]2[C:20]([NH:21][C:22]3[CH:23]=[CH:24][CH:25]=[C:26]([C:28]#[CH:29])[CH:27]=3)=[N:19][CH:18]=[N:17][C:9]2=[CH:10][C:11]=1[O:12][CH2:13][CH2:14][O:15][CH3:16].[ClH:35]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 27.5 °C
Procedure
Erlotinib free base (5 gm, obtained in step-II) is dissolved in chloroform (200 ml) at 25-30° C. to form a clear solution and then is added diethyl ether (50 ml). To the resulting solution is slowly added 15% diethyl ether HCl (5 ml) at 25-30° C. and stirred for 30 minutes at 25-30° C. The material, is filtered washed with a mixture of diethyl ether (10 ml) and chloroform (10 ml), and then dried at 60-65° C. under vacuum to give 4.9 gm of erlotinib hydrochloride [HPLC purity: 99.7%; Content of N-methoxyethyl impurity: 0.24% (at 1.14 RRT)].
Workup
- customto form a clear solution
- customat 25-30° C.
- filtrationThe material, is filtered
- washwashed with a mixture of diethyl ether (10 ml) and chloroform (10 ml)
- customdried at 60-65° C. under vacuum
Sources & evidence
- ORD record
- ord-ec2cd3bd12e046cc9f89eac6eb2d3198
- Source dataset
- uspto-grants-2013_03
- Patent number
- US08389531B2
Reaction notes
Loading…